![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Bictegravir/emtricitabine/tenofovir alafenamide (B/F/TAF) shows high efficacy in clinical study participants infected with HIV-1 subtype F
|
|
|
Glasgow October 5-8, 2020, Glasgow, UK
Reported by Jules Levin
Rima K. Acosta*, Kristen Andreatta, Michelle L. D'Antoni, Sean E. Collins, Hal Martin, and Kirsten L. White
Gilead Sciences, Inc., Foster City, California, USA
![1016201](../images/101620/101620-14/1016201.gif)
![1016202](../images/101620/101620-14/1016202.gif)
![1016203](../images/101620/101620-14/1016203.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|